NCT04707586

Brief Summary

The study was planned to evaluate the effect of local cold application on headache severity in individuals who received intravenous nitroglycerin treatment, which mostly causes headache due to its vasoditator effect. It is thought that the results to be obtained may provide evidence for the development of patient care guidelines.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2020

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 23, 2020

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 13, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2022

Completed
Last Updated

September 10, 2021

Status Verified

September 1, 2021

Enrollment Period

1.1 years

First QC Date

December 23, 2020

Last Update Submit

September 2, 2021

Conditions

Keywords

Cryotherapy, Headache, Nitrates,

Outcome Measures

Primary Outcomes (1)

  • Headache

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The distance between 'no pain' and the mark then defines the subject's pain.

    30 minutes, 3.,6., 9. and 12. hours after nitroglycerin infusion starts

Study Arms (2)

Control

NO INTERVENTION

No application will be made to patients in this group. Routine patient care will be provided. After the patients who develop pain are recorded, the application will be made with a cold application bandage.

experimental group

EXPERIMENTAL

Patients in this group will be applied cold application with cold application bandage for 20 minutes as soon as the infusion begins.

Other: Cold Application

Interventions

Created by the researcher; A bandage with 3 pieces of 13x10 cm cold gel and a cold gel container in which they are placed will be used, which can be adjusted according to the head circumference of the patient between 60-80 cm in length. The ability of the cold gel cups of the bandage to be moved on the bandage will allow comfortable cold application to the patient's bilateral frontotemporal and occipital areas at the same time. After waiting for 20 minutes in the freezer part of the refrigerator, the temperature and temperature of the gels applied and the cold application area before and after each application will be measured and recorded. An Infrared Non-Contact Food Thermometer will be used for temperature measurement of cold gel packs, and an Infrared Non-Contact Thermometer device will be used for temperature measurement of the cold application area.

experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient's volunteerism to participate in the research,
  • Over the age of 18,
  • Being conscious,
  • Any analgesic, NSAID, triptan etc. Not taking antimigren drugs or opioids,
  • No cold allergies.

You may not qualify if:

  • Difficulty in communicating (speaking, perception, language, comprehension problems),
  • Vision and / or hearing loss,
  • Having a cold allergy.
  • Blood pressure above 150/90 mm / Hg.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Nuray Enc

Istanbul, Turkey (Türkiye)

RECRUITING

Yasemin Kalkan Uğurlu

Ordu, 52200, Turkey (Türkiye)

RECRUITING

Related Publications (5)

  • Sprouse-Blum AS, Gabriel AK, Brown JP, Yee MH. Randomized controlled trial: targeted neck cooling in the treatment of the migraine patient. Hawaii J Med Public Health. 2013 Jul;72(7):237-41.

    PMID: 23901394BACKGROUND
  • Demir Y, Khorshid L. The effect of cold application in combination with standard analgesic administration on pain and anxiety during chest tube removal: a single-blinded, randomized, double-controlled study. Pain Manag Nurs. 2010 Sep;11(3):186-96. doi: 10.1016/j.pmn.2009.09.002. Epub 2010 May 31.

    PMID: 20728068BACKGROUND
  • Ertug N, Ulker S. The effect of cold application on pain due to chest tube removal. J Clin Nurs. 2012 Mar;21(5-6):784-90. doi: 10.1111/j.1365-2702.2011.03955.x. Epub 2011 Nov 15.

    PMID: 22082021BACKGROUND
  • Fraser F, Matsuzawa Y, Lee YSC, Minen M. Behavioral Treatments for Post-Traumatic Headache. Curr Pain Headache Rep. 2017 May;21(5):22. doi: 10.1007/s11916-017-0624-x.

  • Ucler S, Coskun O, Inan LE, Kanatli Y. Cold Therapy in Migraine Patients: Open-label, Non-controlled, Pilot Study. Evid Based Complement Alternat Med. 2006 Dec;3(4):489-93. doi: 10.1093/ecam/nel035. Epub 2006 Jun 15.

MeSH Terms

Conditions

Headache

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yasemin K Uğurlu

    Ordu Üniversitesi

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yasemin K Uğurlu, MSCN

CONTACT

Nuray K Enç, Professör

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The quasi-experimental, two-group, pretest-posttest study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant MScN

Study Record Dates

First Submitted

December 23, 2020

First Posted

January 13, 2021

Study Start

December 15, 2020

Primary Completion

January 15, 2022

Study Completion

March 15, 2022

Last Updated

September 10, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

The study protocol will be shared after the study is finished.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will become available towards the end of 2022 and, it can be used for 1 year.
Access Criteria
IPD Sharing will be make only for research.

Locations